.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Farmers Insurance
Boehringer Ingelheim
Mallinckrodt
Teva
US Department of Justice
Fish and Richardson
QuintilesIMS
Novartis
Johnson and Johnson

Generated: February 20, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Patent: PCT/EP99/00048

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Novartis Pharms CorpTYKERBlapatinib ditosylateTABLET;ORAL022059-001Mar 13, 2007RXYesYes➤ Try a Free Trial➤ Try a Free TrialYYTREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC BREAST CANCER WHOSE TUMORS OVEREXPRESS HER2 AND WHO HAVE RECEIVED PRIOR THERAPY INCLUDING ANTHRACYCLINE, A TAXANE AND TRASTUZUMAB
Novartis Pharms CorpTYKERBlapatinib ditosylateTABLET;ORAL022059-001Mar 13, 2007RXYesYes➤ Try a Free Trial➤ Try a Free TrialYYTREATMENT OF PATIENTS WITH BREAST CANCER WHOSE TUMORS OVEREXPRESS THE HER2 RECEPTOR
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist